Prince Michael Jackson Jr.: From Neverland to Hollywood
Prince Jackson, the eldest son of the King of Pop, Michael Jackson, has lived most of his life in the public eye. From walking red carpets to working behind the scenes in media, Prince has forged his own path while honoring his legendary father’s legacy. In this article, we’ll dive deep into
Who is Prince Jackson?
Born as Michael Joseph Jackson Jr. on February 13, 1997, Prince Jackson is the first child of Michael Jackson and his ex-wife Debbie Rowe. Widely known as
Although often shielded from the media during his early years, Prince has gradually become more public with his endeavors, embracing the entertainment industry in his own unique way.
Prince Jackson’s Early Life and Education
Prince spent much of his childhood at Neverland Ranch, alongside his sister Paris Jackson and younger brother Prince Michael Jackson II (also known as
After his father's tragic passing in 2009, Prince and his siblings were placed under the guardianship of their grandmother, Katherine Jackson. He continued his education and later attended Loyola Marymount University, graduating in 2019 with a degree in Business Administration.
Career Path: Prince Jackson in the Media World
Unlike his father, Prince Jackson did not pursue a music career. However, he has expressed a strong interest in the film and television industry, specifically behind the scenes. He co-founded King’s Son Productions, a multimedia company aimed at producing impactful and entertaining content.
While Prince may not be performing on stage, he has made several public appearances, including hosting and producing events that honor his father’s musical legacy. His humanitarian side is also well-noted—he actively participates in charity work, including supporting
Prince Jackson Net Worth in 2025
As of 2025, Prince Jackson’s net worth is estimated to be around $100 million. Most of his wealth stems from Michael Jackson’s estate, which continues to generate millions annually through music royalties, licensing deals, and media projects.
Prince also earns independently through his production company and media ventures. While not as headline-grabbing as other celebrity offspring, his financial standing reflects both his inheritance and business acumen.
Who is Prince Michael Jackson II (Bigi Jackson)?
Prince Michael Jackson II, also known as Bigi Jackson, is Prince’s younger brother, born on February 21, 2002, via surrogacy. He gained public attention when Michael Jackson infamously dangled him over a hotel balcony in Berlin as a baby—an image that remains controversial to this day.
Bigi is much more private than Prince or Paris Jackson and tends to avoid the spotlight. However, he has occasionally made appearances in Jackson family documentaries or charity functions, particularly those that honor their father's legacy.
Prince Jackson and Family Ties
Prince maintains a close relationship with his siblings, Paris and Bigi. The three often come together for charity work and commemorative events related to their father. Prince is especially protective of his younger brother and has spoken out against media scrutiny aimed at him.
He has also expressed admiration for Paris Jackson’s career in modeling and music, highlighting the mutual support that exists among the Jackson siblings.
Is Prince Jackson Married?
As of now, Prince Jackson is not married. He has been in a long-term relationship with his college sweetheart,
Continuing the King of Pop’s Legacy
While Prince Jackson may not be performing on stage like his father, he has embraced a role as a steward of Michael Jackson’s legacy. Whether it’s through philanthropy, production work, or public appearances, Prince aims to honor the memory and contributions of the King of Pop with grace and purpose.
Through his organization, Heal Los Angeles, and media projects via King’s Son Productions, Prince is actively making a difference while maintaining the Jackson family name in a positive light.
Prince Jackson’s Path with Purpose
In a world filled with paparazzi and public pressure, Prince Jackson has managed to carve out a respectful and purposeful identity. From his involvement in film production to his philanthropic ventures, he’s shown that he’s more than just the son of a pop icon.
With an estimated net worth of $100 million, a grounded approach to fame, and a strong bond with his siblings, Prince Jackson represents a new generation of the Jackson legacy—one rooted in creativity, compassion, and quiet strength.
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”
